drugset / Trial / NCT01286441

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Common Warts

NCT01286441

Phase 2 Completed 183 enrolled ViroXis Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Nonclinical studies have shown sandalwood oil to have anti-inflammatory, anti-fungal, antiviral, and anti-bacterial activities. Previous clinical studies have shown East Indian Sandalwood oil to be promising as a treatment for common warts in adults and children. The primary objective of this study is to evaluate the efficacy and safety of 10%, 20%, and 30% East Indian Sandalwood Oil (EISO) ointment compared with the ointment placebo administered twice daily (bid) for 12 weeks for the treatment of common warts (Verruca vulgaris).

Timeline

Start
2012-11
Primary completion
2014-04
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Essential oils Unknown 10 % Topical
Comparator Essential oils Unknown 20 % Topical
Comparator Essential oils Unknown 30 % Topical

Indications